Abstract Aim: This study aims to analyze the health‐related quality of life (HRQoL) and safety outcomes in attention‐deficit/hyperactivity disorder (ADHD)…
Abstract Introduction: While there is increasing evidence of the effects of cannabis‐based medicinal products (CBMPs) on health‐related quality of life…
Abstract Rationale: Cannabis-based medicinal products (CBMPs) have been identified as novel therapeutics for generalised anxiety disorder (GAD) based on pre-clinical…
Abstract Introduction: : There are limited therapeutic options for individuals with fibromyalgia. The aim of this study is to analyze…
Abstract Background There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment…
Abstract Background: In the UK, legislation and regulations governing medical cannabis and over the counter cannabidiol (CBD) wellness products have…
Abstract Introduction: Cannabis-based medicinal products (CBMPs) have been identified as a promising novel therapeutic for symptoms and comorbidities related to…
Abstract Cannabis-based medicinal products (CBMPs) are prescribed with increasing frequency. This study aimed to investigate the perceived stigma attached to…
Abstract Cannabis‐based medicinal products (CBMPs) are an emerging therapeutic option in the management of primary chronic pain, using the role…
Abstract Introduction: Cannabinoids are a group of terpenophenolic compounds derived from the Cannabis sativa L. plant. There is a growing…